ENTITY

Frontera Therapeutics (FRONT HK)

5
Analysis
Health Care • China
Frontera Therapeutics is a global, clinical-stage biotech company creating advanced AAV (adeno-associated virus) gene therapies for rare and common diseases, using their proprietary APEX platform for better vectors and a Suzhou GMP facility for low-cost, high-quality production.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x